Episode 9: The Changing Treatment Paradigm of HER2+ Metastatic Breast Cancer

SABCS 2021: Small Molecule Clinical Trials in R/R HER2+ mBC

Rounding out their conversation on SABCS 2021, Dr. VK Gadi and experts discuss small molecule-based treatment strategies for relapsed/refractory HER2+ metastatic breast cancer.

The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive. View our complete video library.

Translate »